HAVN Life Sciences Inc. (OTCPK: HAVL.F)
Health Care · Biotechnology · CA
$—
— today · — 1Y
HAVN Life Sciences Inc. (OTCPK: HAVL.F) operates in the Biotechnology industry within the Health Care sector. The company is valued at $29.00.
trading between 0.00 and 0.00.
Tweenvest scores HAVN Life Sciences Inc. across four factors: quality 45/100, value 51/100. Its strongest factor is value.
HAVL.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $29.00
- Revenue (TTM)
- $440.11K
- P/E
- —
- EPS
- -2.20
- Dividend yield
- —
- Beta (5Y)
- 90.43
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 28.65M
- Employees
- —
- Next earnings
- —
About HAVN Life Sciences Inc.
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
- ISIN
- CA4196213058
- Founded
- 2020
- Listed since
- Sep 8, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gelesis Holdings, Inc.OTCPK: GLSH.Q | $73.00 | $— | — |
| Athersys, Inc.OTCPK: ATHX.Q | $62.00 | $0.00 | -90.00% |
| Genocea Biosciences, Inc.OTCPK: GNCA.Q | $59.00 | $0.00 | — |
| Mymetics CorporationOTCPK: MYMX | $46.00 | $— | — |
| TetraLogic Pharmaceuticals CorporationOTCPK: TLOG | $24.00 | $0.00 | — |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $0.00 | — |
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $— | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | — |
Figures last refreshed Oct 18, 2026.